Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs

doi:10.1016/0168-3659(95)00129-8

Journal of Controlled Release

Volume 39, Issue 1, March 1996, Pages 17-25

https://doi.org/10.1016/0168-3659(95)00129-8 Get rights and content

Abstract

Chitosan microspheres were prepared by a novel precipitation process using sodium sulfate as precipitant. Low, medium, and high molecular weight chitosan was chosen for the formulation of microspheres. The extent of precipitation was controlled by the concentration of sodium sulfate and monitored by turbidity measurement. The amount of sodium sulfate required for the preparation of the microspheres depended on the molecular weight of chitosan. The particle size was determined by photon correlation spectroscopy (PCS) and centrifugal sedimentation. The morphological characteristics were examined using a scanning electron microscope (SEM). The surface charge was measured by microelectrophoresis. After preparation the loading property with various anti-inflammatory drugs was investigated using spectrophotometry. The influence of surface adsorption on the drug modification was controlled by differential scanning calorimetry (DSC). Drug liberation was tested in vitro using side-by-side diffusion cells with a dialysis membrane made of cellulose acetate. The highest loading (up to 30.5% relative to the polymer mass) was achieved with prednisolone sodium phosphate (PSP). The adsorbed drug was present in an amorphous form. The drug release from the microspheres was dependent on the drug-polymer ratio.

References (30)

R. Diepold et al.
Distribution of poly-hexyl-2-cyano-[3-¹⁴C]acrylate nano-particles in healthy and chronically inflamed rabbit eyes
Int. J. Pharm.
(1989)
C.M. Lehr et al.
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Int. J. Pharm.
(1992)
H.L. Lueβen et al.
Bioadhesive polymers for the peroral delivery of peptide drugs
J. Control. Release
(1994)
P.C. Berscht et al.
Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics
Biomaterials
(1994)
Y. Kawashima et al.
Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan
J. Pharm. Sci.
(1985)
S. Shiraishi et al.
Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation
J. Control. Release
(1993)
T. Imai et al.
Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans
Int. J. Pharm.
(1991)
J. Akbuga et al.
Preparation and evaluation of cross-linked chitosan microspheres containing furosemide
Int. J. Pharm.
(1994)
J.K. Haleblian
Pharmaceutical applications of polymorphism
J. Pharm. Sci.
(1975)
C. Kienzle-Sterzer et al.
Solution properties of chitosan: chain conformation

J. Kreuter

Peroral administration of nanoparticles

Adv. Drug Deliv. Rev.

(1991)

L. Illum et al.

Targeting of microspheres to sites of inflammation

Int. J. Pharm.

(1989)

H.O. Alpar et al.

The transport of microspheres from the gastro-intestinal tract to inflammatory air pouches in the rat

J. Pharm. Pharmacol.

(1989)

S. Hirano et al.

Bio-compatibility of chitosan by oral and intravenous administration

Polym. Eng. Sci.

(1988)

W.-M. Hou et al.

Sustained release of indomethacin from chitosan granules

Chem. Pharm. Bull.

(1985)

Cited by (369)

3D-printed prednisolone phosphate suppositories with tunable dose and rapid release for the treatment of inflammatory bowel disease
2024, International Journal of Pharmaceutics
Established medicines are often not tailored to the needs of the pediatric population, causing difficulties with administration or dosing. Three-dimensional (3D) printing technology allows novel approaches for compounding of personalized medicine, as is exemplified in this study for the automated compounding of rectal preparations for children. We investigated the material requirements to print prednisolone phosphate-loaded suppositories with tunable dose and rapid drug release for the treatment of inflammatory bowel diseases. Three formulations containing 4 % w/w prednisolone sodium phosphate (PSP) and different amounts of hydroxypropyl cellulose (HPC) and mannitol as excipients were printed as suppositories with a fused deposition modeling (FDM) 3D-printer. Dissolution studies showed that the PSP release rate was increased when higher weight fractions of mannitol were added as a pore former, with 90 % drug release within 30 min for mannitol 48 % w/w. We further printed suppositories with 48 % mannitol with different infill densities and dimensions to tune the dose. Our findings demonstrated that 3D-printed suppositories with PSP doses ranging from 6 to 30 mg could be compounded without notably affecting the dissolution kinetics, ensuring equivalent therapeutic efficacies for different doses.
Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives
2024, Drug Discovery Today
Breast cancer is the most common and malignant tumor among women. Chitosan (CS)-based nanoparticles have been introduced into breast cancer therapy as a way to increase the targeted delivery of drugs and genes to the tumor site. CS nanostructures suppress tumorigenesis by enhancing both the targeted delivery of cargo (drug and gene) and its accumulation in tumor cells. The tumor cells internalize CS-based nanoparticles through endocytosis. Moreover, chitosan nanocarriers can also induce phototherapy-mediated tumor ablation. Smart and multifunctional types of CS nanoparticles, including pH-, light- and redox-responsive nanoparticles, can be used to improve the potential for breast cancer removal. In addition, the acceleration of immunotherapy by CS nanoparticles has also been achieved, and there is potential to develop CS-nanoparticle hydrogels that can be used to suppress tumorigenesis.
Sustainable functionalized chitosan based nano-composites for wound dressings applications: A review
2023, Environmental Research
Functionalized chitosan nanocomposites have been studied for wound dressing applications due to their excellent antibacterial and anti-fungal properties. Polysaccharides show excellent antibacterial and drug-release properties and can be utilized for wound healing. In this article, we comprise distinct approaches for chitosan functionalization, such as photosensitizers, dendrimers, graft copolymerization, quaternization, acylation, carboxyalkylation, phosphorylation, sulfation, and thiolation. The current review article has also discussed brief insights on chitosan nanoparticle processing for biomedical applications, including wound dressings. The chitosan nanoparticle preparation technologies have been discussed, focusing on wound dressings owing to their targeted and controlled drug release behavior. The future directions of chitosan research include; a) finding an effective solution for chronic wounds, which are unable to heal completely; b) providing effective wound healing solutions for diabetic wounds and venous leg ulcers; c) to better understanding the wound healing mechanism with such materials which can help provide the optimum solution for wound dressing; d) to provide an improved treatment option for wound healing.
Evaluation of methotrexate encapsulated polymeric nanocarrier for breast cancer treatment
2023, Colloids and Surfaces B: Biointerfaces
Herein, Methotrexate-loaded chitosan nanoparticles (Meth-Cs-NPs) was formulated through single-step self-assembly by incorporating the ionic-gelation method. Chitosan was cross-linked with Methotrexate via a sodium tripolyphosphate (STPP) where 49 % Methotrexate was loaded in the nanoparticles (∼143 nm) and zeta potential of 34 ± 3 mV with an entrapment efficiency of 87 %. The efficacy of nanoparticles was assessed for chemically induced breast cancer treatment in the Sprague Dawley rats model. These Meth-Cs-NPs followed the Korsmeyer-Peppas model in-vitro release kinetics. Nanoparticles were further evaluated for in-vitro efficacy on triple-negative breast cancer (MDA-MB-231) cell lines. The MTT assay studies revealed that even slight exposure to Meth-Cs-NPs (IC₅₀ = 15 µg/mL) caused 50 % cell death in 24 h. Further, hemocompatibility studies of Meth-Cs-NPs were performed, deciphered that Meth-Cs-NPs were biocompatible (hemolysis < 2 %). Additional cellular uptake was evaluated by confocal imaging. Moreover, an in-vivo pharmacokinetic study of nanoparticles in rats displayed increased plasma concentration of the drug and retention time, whereas a decrease in cellular clearance compared to free Methotrexate. Further, anti-tumor efficacy studies revealed that nanoparticles could reduce tumor volume from 1414 mm³→385 mm³ compared to free Methotrexate (1414 mm³→855 mm³). The current study presents encouraging prospects of Meth-Cs-NPs to be used as a viable breast cancer treatment modality.
Nanoencapsulation of hydroxytyrosol in chitosan crosslinked with sodium bisulfate tandem ultrasonication: Techno-characterization, release and antiproliferative properties
2022, Ultrasonics Sonochemistry
Citation Excerpt :
On the other hand, sulfate anions including sodium sulfate and potassium bisulfate, among others take part in ionic gelation with chitosan. Sodium sulfate has been used for precipitation-coacervation of chitosan to yield nanoparticles having high protein loading efficiencies [31], precipitation/coacervation of chitosan to yield nanocapsules for efficient loading of ovalbumin [30], crosslinking of chitosan into microsphares for encapsulating the cell protein antigen of Helicobectar pylori [34], crosslinking of chitosan to yield nontoxic in situ injectable hydrogels for sustained release of curcumin [50], layer-by-layer self-assembly of chitosan into microcapsules for the spontaneous loading of heparin [47], and precipitation of chitosan for the formulation of microspheres loading different steroidal anti-inflammatory drugs [7]. However, these anionic substances are not recognized as safe by the U.S FDA.
This research includes production of chitosan nanocapsules through ionic gelation with sodium bisulfate for nanoencapsulation of hydroxytyrosol (HT) using ultrasonication in tandem. The resulting nanocapsules encapsulating HT were analyzed for particle size, ζ-potential, packaging characteristics, FESEM, ATR-FTIR, XRD, DSC, in vitro release, antioxidant potential and antiproliferative properties. The nanocapsules (size 119.50–365.21 nm) were spherical to irregular shaped with positive ζ-potential (17.50–18.09 mV). The encapsulation efficiency of 5 mg/g HT (HTS1) and 20 mg/g HT (HTS2) was 77.13% and 56.30%, respectively. The nanocapsules were amorphous in nature with 12.34% to 15.48% crystallinity and crystallite size between 20 nm and 27 nm. Formation of nanocapsules resulted in increasing the glass transition temperature. HTS2 delivered 67.12% HT (HTS1 58.89%) at the end of the simulated gastrointestinal digestion. The nanoencapsulated HT showed higher antioxidant and antiproliferative (against A549 and MDA-MB-231 cancer cell lines) properties than the free HT.
Rod-shaped keratin nanoparticles extracted from human hair by acid hydrolysis as photothermally triggered berberine delivery system
2022, Advanced Powder Technology
Human hair can be a sustainable keratin source to prepare cytocompatible drug nanocarriers. A simple and effective methodology to create rod-like keratin nanoparticles (KNPs) using acidic hydrolysis was reported in this work. The extracted KNPs were characterized by infrared spectroscopy (FTIR), X-Ray diffraction (XRD), thermal analysis (TG and DSC), Zeta potential measurements, scanning electron microscopy (SEM), and transmission electron microscopy (TEM). The KNPs presented an amorphous structure with a smaller average size and higher aspect ratio than KNPs created from previously reported alkaline methods. Furthermore, cell viability assays confirmed that the extracted KNPs are cytocompatible toward adipose mesenchymal stem cells (ADSCs) and healthy cells of the African green monkey (VERO cells). The material was evaluated as berberine (BERB) nanocarrier, a drug with anticancer activity. The BERB was associated with KNPs by adsorption. The rod-shaped KNPs presented a type II adsorption profile toward BERB, adsorbing approximately 168.05 ± 1.44 mg/g. BERB is a cationic species capable of interacting with negatively charged KNPs (Zeta potential equal to −33.8 mV at pH 8.0). After BERB adsorption, the KNPs/BERB Zeta potential is reduced to −10.14 mV (pH 8.0). The KNPs exhibited strong photothermal properties, which improved and enhanced the BERB desorption. The photothermal KNPs responsiveness promoted a sustained BERB release. The KNPs/BERB shows cytotoxity against colon adenocarcinoma cells (HT-29 cells). Therefore, the extracted rod-shaped KNPs can be alternative nanocarriers for BERB delivery.

View all citing articles on Scopus

View full text

Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs

Abstract

Int. J. Pharm.

Int. J. Pharm.

J. Control. Release

Biomaterials

J. Pharm. Sci.

J. Control. Release

Int. J. Pharm.

Int. J. Pharm.

J. Pharm. Sci.

Adv. Drug Deliv. Rev.

Targeting of microspheres to sites of inflammation

Int. J. Pharm.

The transport of microspheres from the gastro-intestinal tract to inflammatory air pouches in the rat

J. Pharm. Pharmacol.

Bio-compatibility of chitosan by oral and intravenous administration

Polym. Eng. Sci.

Sustained release of indomethacin from chitosan granules

Chem. Pharm. Bull.